Differences in Vancomycin Clearance between Trauma and Medical Intensive Care Unit Patients

Area of Science:

• Pharmacokinetics
• Intensive Care Medicine
• Nephrology

Background:

• Vancomycin pharmacokinetics vary significantly in intensive care unit (ICU) patients.
• Understanding these differences is crucial for optimizing vancomycin dosing, especially in critically ill populations.

Purpose of the Study:

• To compare vancomycin pharmacokinetics between trauma ICU (TICU) and medical ICU (MICU) patients.
• To investigate the impact of continuous renal replacement therapy (CRRT) on vancomycin clearance (CL) and identify associated factors.

Main Methods:

• Retrospective analysis of vancomycin trough levels and clinical data from ICU patients.
• Stratification of patients based on the presence or absence of CRRT.
• Comparison of vancomycin CL and influencing factors between TICU and MICU groups.

Main Results:

• In non-dialyzed patients, vancomycin CL was higher in TICU patients compared to MICU patients.
• No significant difference in vancomycin CL was observed between trauma and medically ill patients receiving CRRT.
• Creatinine clearance was the sole factor associated with vancomycin CL in non-dialyzed patients; no factors were associated in the CRRT group.

Conclusions:

• Vancomycin dosage adjustments based on body weight are recommended for non-dialyzed trauma ICU patients.
• For patients undergoing CRRT in either ICU setting, fixed vancomycin dosing appears appropriate, irrespective of individual patient characteristics.